Posted by Michael Wonder on 26 Sep 2021
Australia secures supply of drug that treats arthritis and Covid
25 September 2021 - Health Minister Greg Hunt has secured an extra supply of a rheumatoid arthritis drug to treat critically ill Covid-19 patients.
Manufacturer Roche previously flagged a shortage of tocilizumab – sold under the brand name Actemra – with the Therapeutic Goods Administration, which this month said supply would be “extremely limited” until early next year.
The shortage saw stock reduced to 25% of usual levels for public hospitals and 10% for private hospitals and community pharmacy.
